We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by iNova Pharmaceuticals (Australia) Pty Ltd
I, Rowena Love, as a delegate of the Secretary to the Department of Health, on receipt of an application from iNova Pharmaceuticals (Australia) Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989, the restricted representations described in paragraph (A), for use in advertising the products identified in paragraph (B) to consumers.
- "For the temporary relief of pain and discomfort associated with headache, tension headache, migraine headache, osteoarthritis, arthritis, cold & flu symptoms, toothache, dental procedures, muscular aches, sore throat and period pain."
- NYAL PARACETAMOL PLUS CAFFEINE tablet blister pack (AUST R 376448)
Dated this 16th day of June 2022.
Signed electronically
Rowena Love
Delegate of the Secretary to the Department of Health
Advertising and Compliance Education and Policy Section
Regulatory Compliance Branch